Chitose Internasional Tbk. vs Charlie Hospital Semarang Tbk. — how do they compare? Chitose Internasional Tbk. trades at Rp166 (market cap 166B, 77.9K 24h volume), while Charlie Hospital Semarang Tbk. trades at Rp256 (market cap 715.5B, 30.64M 24h volume). The key difference: Charlie Hospital Semarang Tbk. is far larger — about 4.3× Chitose Internasional Tbk.'s market cap, and Charlie Hospital Semarang Tbk. is more actively traded (30.64M versus 77.9K). Which is the better fit depends on your goals.
| CINT | RSCH | |
|---|---|---|
Market Cap | 166B | 715.5B |
Volume | 77.9K | 30.64M |
Lot | 779 | 306.41K |
Turnover | 12.99M | 7.98B |
Average Price | 166.74 | 260.34 |
Value | 12.99M | 7.98B |
Indicative Equilibrium Price | 168 | 256 |
Indicative Equilibrium Volume | 16 | 512 |
Trailing returns across standard periods
Latest headlines on both assets
PT Chitose Internasional Tbk (the Company) formerly PT Chitose Indonesia Manufacturing was established based on Notarial Deed No. 21 dated June 15, 1978 of Widyanto Pranamihardja, S.H., notary in Bandung. The name was changed to PT Chitose Internasional on October 4, 2013. The company with brand Chitose has a high market share in all product categories, including folding chair, hotel, restaurant, food coourt, office and working chair and chair school.
Read more on CINT →PT Charlie Hospital Semarang, Tbk (the "Company") was established based on Deed No. 35 dated 11 February 2019, which was made before Notary Nur Hadi, SH, MKn, notary in Kendal Regency and has been approved by the Minister of Law and Human Rights of the Republic of Indonesia based on Decree No. AHU-0008598.AH.01.01. Year 2019 February 11, 2019. The company started its commercial operations on September 23, 2019.
Read more on RSCH →